Literature DB >> 19530133

Genetic regulatory networks of nephrogenesis: deregulation of WT1 splicing by benzo(a)pyrene.

Kenneth S Ramos1, Adrian Nanez.   

Abstract

Recent studies have identified AHR as a master regulator of Wilms' tumor suppressor gene (WT1) signaling in the developing kidney. Activation of AHR signaling by environmental chemical is associated with proteasome-mediated degradation of AHR protein, disruption of WT1 alternative splicing, and marked alterations in the regulation of genetic programs of developmental progression in the developing kidney. The complexity of genetic regulatory networks of nephrogenesis controlled by AHR-WT1 interactions will be discussed here with particular emphasis given to the biological and medical consequences that may result from deficits in nephrogenesis that compromise reserve capacity and renal function later in life. Understanding the impact of early-life environmental exposures to chemicals that disrupt AHR signaling can help minimize negative health consequences to pregnant women and their offspring.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19530133     DOI: 10.1002/bdrc.20148

Source DB:  PubMed          Journal:  Birth Defects Res C Embryo Today        ISSN: 1542-975X


  3 in total

Review 1.  Precision prevention: A focused response to shifting paradigms in healthcare.

Authors:  Kenneth S Ramos; Emma C Bowers; Marco A Tavera-Garcia; Irma N Ramos
Journal:  Exp Biol Med (Maywood)       Date:  2019-03

2.  Epigenetic control of embryonic renal cell differentiation by L1 retrotransposon.

Authors:  Kenneth S Ramos; Diego E Montoya-Durango; Ivo Teneng; Adrian Nanez; Vilius Stribinskis
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-03-07

3.  Association of solid fuel use with risk of stunting in children living in China.

Authors:  Weigang Liang; Beibei Wang; Guofeng Shen; Suzhen Cao; Bertrand Mcswain; Ning Qin; Liyun Zhao; Dongmei Yu; Jicheng Gong; Shanshan Zhao; Yawei Zhang; Xiaoli Duan
Journal:  Indoor Air       Date:  2019-12-06       Impact factor: 6.554

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.